Thyroxine-binding globulin inhibitors
DBCAT004603Pharmacologic class
Drugs that decrease the level of TBG in the plasma. A DrugBank category of 38 drugs. 35 of them are approved.
- Drugs
- Amcinonide
- Asparaginase Erwinia chrysanthemi
- Asparaginase Escherichia coli
- Beclomethasone dipropionate
- Betamethasone
- Ciclesonide
- Clobetasol
- Clobetasol propionate
- Danazol
- Fluocinonide
- Fluorometholone
- Fluticasone
- Fluticasone furoate
- Fluticasone propionate
- Medrysone
- Meprednisone
- Methyltestosterone
- Mometasone
- Mometasone furoate
- Nandrolone
- Nandrolone decanoate
- Nandrolone phenpropionate
- Niacin
- Oxandrolone
- Oxymetholone
What you can answer from here — as of December 09, 2019
Which targets do Thyroxine-binding globulin inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account